Molecular techniques v. conventional culture: Should there really be a debate?
Main Article Content
Abstract
-
Downloads
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
How to Cite
References
1. World Health Organization. The top 10 causes of death. 7 August 2024. https://www. who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death (accessed 12 April 2025).
2. Statistics South Africa. Causes of death 2013. 4 December 2024. https://www.statssa. gov.za/?page_id=737&id=3 (accessed 12 April 2025).
3. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in humanseptic shock. Crit Care Med 2006;34(6):1589-1596. https://doi.org/10.1097/01.
CCM.0000217961.75225.E9
4. Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia: An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med 2019;200(7):e45-e67. https://doi.org/10.1164/rccm.201908-1581ST
5. Buchan BW, Armand-Lefevre L, Anderson N. Molecular diagnosis of pneumonia (including multiplex panels). Clin Chem 2021;68(1):59-68. https://doi.org/10.1093/ clinchem/hvab143
6. FerrerJ,ClariMÁ,GiménezE,etal.TheBiofire®Filmarray®PneumoniaPluspanelfor management of lower respiratory tract infection in mechanically-ventilated patients in the COVID-19 era: A diagnostic and cost-benefit evaluation. Diagn Microbiol Infect Dis 2023;105(2):115847. https://doi.org/10.1016/j.diagmicrobio.2022.115847
7. Buchan BW, Windham S, Balada-Llasat JM, et al. Practical comparison of the BioFire FilmArray Pneumonia Panel to routine diagnostic methods and potential impact on antimicrobial stewardship in adult hospitalized patients with lower respiratory tract infections. J Clin Microbiol 2020;58(7):10.1128/jcm.00135-20. https://doi. org/10.1128/JCM.00135-20
8. Worodria W, Andama A, Sanyu I, et al. Afr J Thoracic Crit Care Med 2025;31(2):e2415.